The House and Senate now must arrive at final version of broader opioid-abuse-prevention legislation. Meanwhile, state legislatures and executive branches are taking action to advance electronic prescribing as well.
House Energy & Commerce Committee Vice Chairman Joe Barton (R-TX) toured an Albertson’s pharmacy in Arlington, Tex., as part of the NACDS RxIMPACT advocacy program.
Rep. Buddy Carter (R-GA), the only pharmacist currently serving in Congress, toured a Kroger pharmacy in Waycross, Ga., this week as part of the NACDS RxIMPACT grassroots advocacy program.
NACDS recently outlined a compelling case detailing pharmacy’s quantifiable and demonstrated value in a letter to the bipartisan Health Care Innovation Caucus.
NACDS member companies hosted 11 recent NACDS RxIMPACT pharmacy tours with members of Congress and staff back home in their states, bringing the 2018 total to 62 so far.
NACDS RxIMPACT pharmacy tours engage members of Congress and their staff on the vital healthcare services pharmacists provide on a daily basis.
The Senate Health, Education, Labor and Pensions Committee passed legislation by Sen. Sue Collins (R-ME) that would do away with efforts to prevent pharmacists from informing patients when a medication can be purchased at a lower price without using insurance.
NACDS RxIMPACT pharmacy advocates are urging Senators to sign a letter to U.S. Secretary of Health and Human Services Secretary Alex Azar that is being led by Sen. Shelley Moore Capito (R-WV) and Sen. Jon Tester (D-MT).
The Every Prescription Conveyed Securely Act (H.R. 3528) would require electronic prescribing for Schedule II through V controlled substances prescriptions covered under Medicare Part D to help prevent fraud, abuse and waste.
The Senate Finance Committee passed the Every Prescription Conveyed Securely Act (S. 2460). The House of Representatives Energy and Commerce Committee passed companion legislation (H.R. 3528) on May 9.
